In breast cancer, IL-17RB engagement by IL-17B triggers TRAF6 recruitment to IL-17RB, NF-κB activation and induction of the bcl-2 gene to inhibit apoptosis [34]. This evidence concerns the gene IL17RB and breast cancer.